SNOA Insider Trading Activity and SEC Form 4 Filings
SNOA insider trading summary
No open-market insider purchases or sales of Sonoma Pharmaceuticals, Inc. (SNOA) have been reported on SEC Form 4 in the past 12 months.
Latest SNOA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 13, 2018 | Robert E Miller | Chief Financial Officer | Buy | $5K (1,200 @ $4.10) |
| Mar 12, 2018 | Robert E Miller | Chief Financial Officer | Buy | $5K (1,200 @ $4.03) |
| Mar 12, 2018 | Robert E Miller | Chief Financial Officer | Buy | $5K (1,200 @ $4.03) |
| Mar 9, 2018 | Robert E Miller | Chief Financial Officer | Buy | $5K (1,200 @ $3.90) |
| Mar 8, 2018 | James J Schutz | Chief Executive Officer | Buy | $10K (2,473 @ $3.99) |
| Nov 30, 2017 | James J Schutz | Chief Executive Officer | Buy | $2K (345 @ $4.95) |
| Nov 29, 2017 | Robert E Miller | Chief Financial Officer | Buy | $3K (500 @ $5.03) |
| Nov 29, 2017 | James J Schutz | Chief Executive Officer | Buy | $2K (400 @ $5.03) |
| Nov 29, 2017 | Robert E Miller | Chief Financial Officer | Buy | $6K (1,290 @ $5.02) |
| Nov 24, 2017 | James J Schutz | Chief Executive Officer | Buy | $1K (254 @ $5.05) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.